Companies/RO/HEAL

S.C. HELIOS S.A.

Last · BVBRON 21.000.00 (0.00%)stale · yahoo · 288h ago
Market cap
P/E · TTMfwd · eps
Betavs S&P 500
Div yieldannual · TTM
52w range
RON 15.00RON 25.80
Volume3session

Issuer

Legal nameS.C. HELIOS S.A.
HQRO (RO)
ListingRO HEAL
ISINROHEALACNOR2
CurrencyUSD
Entity registryisin:ROHEALACNOR2
Org IDHEAL
Websitem.bvb.ro
Employees64
AddressHelios SA (Romania) Str. Principala, Nr. 236 417020, Astileu
Loading chart…

OpenFilings analyst

Our analyst

Agentic read of the latest earnings call — recommendation updates when we process a new transcript. Research synthesis, not investment advice.

Operational recovery is real, but project concentration, limited guidance, and leverage cost prevent a clean buy case.

Latest call · 2026-09-02

Hold: H1 revenue rose 41% to RON 126m, gross margin increased 49%, and operating loss narrowed sharply to RON 1.19m from RON 17m, but RON 8.5m net profit was helped by the Elian sale.

The improvement is encouraging, yet earnings quality remains mixed because growth is heavily tied to public-sector/NRRP projects, while management gave no quantified forward guidance and the new bond carries a high 10.6% coupon.

Themes
  • H1 2026 Results
  • Public Sector Projects
  • Nrpp Funding
  • Education Growth
  • Dendrio
  • Nenos Ai Agents
+2

Near term

Second-half performance depends on converting delayed public-sector and private-sector projects amid political instability and elongated sales cycles.

Education growth may normalize after an exceptional NRRP-funded first half.

The proposed buyback of up to 142 million shares, approximately 22% of total shares and funded by RON 25m of asset-sale proceeds, could support the stock if approved and executed.

Longer term

Dendrio remains the dominant earnings driver, with exposure to public-sector budgets, infrastructure delivery delays, semiconductor shortages, and geopolitical disruption.

Nenos could become a more valuable growth platform if its AWS partnership and prospective Anthropic certification translate into recurring AI-agent and software revenue over the next 6–12 months.

The group’s restructuring and cost reductions materially improved profitability, but investors need evidence that margins can remain positive without exceptional public-funded projects or asset-sale gains.

The 10.6% BNET31E coupon raises financing costs and increases execution pressure while the company continues investing in growth and buybacks.

Red flags

No analyst Q&A took place, so management’s claims about valuation, AI growth, and future buybacks were not challenged.

Net profit is not representative of recurring operating performance because it was positively affected by the Elian disposal.

Management did not quantify the updated 2026 budget, second-half revenue, profitability, cash flow, or debt targets.

The transcript identifies significant dependence on public-sector and NRRP-funded activity, but does not quantify its share of revenue or backlog.

The supplied issuer name is CONECT BUSINESS PARK S.A., while the transcript concerns Bittnet Group; this issuer/transcript mismatch should be resolved before relying on the call for an investment decision.

Recommendation history

OpenFilings analyst view from primary-source filings and earnings calls — not investment advice.

Earnings transcripts

2 recent

Documents